Tested Applications
| Positive WB detected in | mouse brain tissue, HepG2 cells, HeLa cells, A431 cells |
| Positive IP detected in | HeLa cells |
| Positive IHC detected in | human colon cancer tissue, human kidney tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells, HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
17499-1-AP targets MYO1A in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag11682 Product name: Recombinant human MYO1A protein Source: e coli.-derived, T-HIS Tag: 6*His Domain: 1-350 aa of BC059387 Sequence: MPLLEGSVGVEDLVLLEPLVEESLLKNLQLRYENKEIYTYIGNVVISVNPYQQLPIYGPEFIAKYQDYTFYELKPHIYALANVAYQSLRDRDRDQCILITGESGSGKTEASKLVMSYVAAVCGKGEQVNSVKEQLLQSNPVLEAFGNAKTIRNNNSSRFGKYMDIEFDFKGSPLGGVITNYLLEKSRLVKQLKGERNFHIFYQLLAGADEQLLKALKLERDTTGYAYLNHEVSRVDGMDDASSFRAVQSAMAVIGFSEEEIRQVLEVTSMVLKLGNVLVADEFQASGIPASGIRDGRGVREIGEMVGLNSEEVERALCSRTMETAKEKVVTALNVMQAQYARDALAKNIY Predict reactive species |
| Full Name | myosin IA |
| Calculated Molecular Weight | 1043 aa, 118 kDa |
| Observed Molecular Weight | 130 kDa |
| GenBank Accession Number | BC059387 |
| Gene Symbol | MYO1A |
| Gene ID (NCBI) | 4640 |
| RRID | AB_2148172 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UBC5 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for MYO1A antibody 17499-1-AP | Download protocol |
| IHC protocol for MYO1A antibody 17499-1-AP | Download protocol |
| IP protocol for MYO1A antibody 17499-1-AP | Download protocol |
| WB protocol for MYO1A antibody 17499-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The MYO1A Polyclonal antibody (Cat# 17499-1-AP) has 3 citations published in Cell Reports Medicine, Cell Molecular Biology Letters, and Clinical Science (London). The associated research fields include personalized drug screening in gastric cancer organoids, congenital cataract formation in mice, and arterial calcification mechanisms in diabetes. Applications cited are Western blot and immunoprecipitation.
| Species | Application | Title |
|---|---|---|
Cell Rep Med Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer | ||
Cell Mol Biol Lett Loss of alpha-kinase 1 contributes to the formation of congenital cataracts in mice. | ||
Clin Sci (Lond) A new mechanism of arterial calcification in diabetes: interaction between H3K18 lactylation and CHI3L1 |





















